Ankara : The Department of Moleculer Biology and Genetics and the Institute of Engineering and Science of Bilkent University, 2009.Thesis (Ph.D.) -- Bilkent University, 2009.Includes bibliographical refences.The aim of the first part of this study was to find out the expression profiles of the genes, which were selected from the former BRCA1-induced gene list (OVCA1, OVCA2, ERBIN, RAD21, XRN2, RENT2, SMG1 and MAC30) in normal-matched primary breast tumors and to correlate the gene expression profiles of selected candidate genes with BRCA1 and various pathology parameters. Among the target genes, the expression of ERBIN, SMG1 and RAD21 were found to be highly correlated with that of BRCA1 both in BRCA1 up- and down-regulated cells and ...
Breast cancer is a complex disease exhibiting a great degree of heterogeneity due to different molec...
The goal of improving systemic treatment of breast cancers is to evolve from treating every patient ...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
Abstract Background Accuracy in the diagnosis of breast cancer and classification of cancer subtypes...
Background: HER2 positive breast cancer (HER2+ BC) is a heterogeneous disease. Presenting features, ...
BackgroundBreast cancer metastasis is a highly prevalent cause of death for European females. DNA mi...
Background: Gene expression measurements from breast cancer (BrCa) tumors are established clinical p...
Background: gene expression profiling has distinguished sporadic breast tumour classes with genetic ...
In this review we provide a systematic analysis of transcriptomic signatures derived from 42 breast ...
Cataloged from PDF version of article.Background: Accuracy in the diagnosis of breast cancer and cla...
Breast cancer is the most common cancer in women worldwide. Most breast cancers are hormone related ...
Breast cancer is the leading cause of cancer-related death in women worldwide. Invasive ductal carci...
microRNA expression signatures can differentiate normal and breast cancer tissues and can define spe...
© 2011 Dr. Max YanBasal breast cancers are a subgroup of breast cancers with a distinctive gene expr...
Background: HER2 positive breast cancer (HER2+ BC) is a heterogeneous disease. Presenting features, ...
Breast cancer is a complex disease exhibiting a great degree of heterogeneity due to different molec...
The goal of improving systemic treatment of breast cancers is to evolve from treating every patient ...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...
Abstract Background Accuracy in the diagnosis of breast cancer and classification of cancer subtypes...
Background: HER2 positive breast cancer (HER2+ BC) is a heterogeneous disease. Presenting features, ...
BackgroundBreast cancer metastasis is a highly prevalent cause of death for European females. DNA mi...
Background: Gene expression measurements from breast cancer (BrCa) tumors are established clinical p...
Background: gene expression profiling has distinguished sporadic breast tumour classes with genetic ...
In this review we provide a systematic analysis of transcriptomic signatures derived from 42 breast ...
Cataloged from PDF version of article.Background: Accuracy in the diagnosis of breast cancer and cla...
Breast cancer is the most common cancer in women worldwide. Most breast cancers are hormone related ...
Breast cancer is the leading cause of cancer-related death in women worldwide. Invasive ductal carci...
microRNA expression signatures can differentiate normal and breast cancer tissues and can define spe...
© 2011 Dr. Max YanBasal breast cancers are a subgroup of breast cancers with a distinctive gene expr...
Background: HER2 positive breast cancer (HER2+ BC) is a heterogeneous disease. Presenting features, ...
Breast cancer is a complex disease exhibiting a great degree of heterogeneity due to different molec...
The goal of improving systemic treatment of breast cancers is to evolve from treating every patient ...
Breast cancer is the 2nd most common cancer globally with nearly 1.7 million new cases of all cancer...